维普期刊资源整合服务平台（V6.5）

154篇 您的检索式：作者名="Engelman A"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	ENGELMAN J A ZEJNULLAHU K MITSUDOMI T	2007	Science2007，316，5827：	1
2	Caveolin-3 null mice show a loss of caveolae,changes in the microdomain distribution of the dystrophin- glycoprotein complex,and t-tubule abnormalities显示文摘	Galbiati F Engelman J A Volonte D	2001	The Journal of Biological Chemistry2001，276，21：	1
3	Tar- geted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts-transient activation of p38 mitogen- activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube for- mation显示文摘	Galbiati F Volonte D Engelman J A	1999	Journal of Biological Chemistry1999，274，30：	1
4	Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers 显示文摘	Engelman J A Chert L Tan X	2008	Nat Med2008，14，12：	1
5	Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study显示文摘	D Ross Camidge Yung-Jue Bang Eunice L Kwak A John Iafrate Marileila Varella-Garcia Stephen B Fox Gregory J Riely Benjamin Solomon Sai-Hong I Ou Dong-Wan Kim Ravi Salgia Panagiotis Fidias Jeffrey A Engelman Leena Gandhi Pasi A J?nne Daniel B Costa Geoffrey	2012	Lancet Oncology2012，，10：	1
6	Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer显示文摘	Engelman J A Janne P A		0，，10：	1
7	Critical contacts between HIV-I integrase and viral DNA identified by structure-based analysis and photo-crosslinking显示文摘	Jenkins TM Esposito D Engelman A	1997	EMBO J1997，16，22：	1
8	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	ENGELMAN J A ZEJNULLAHU K MITSUDOMI T	2007	Science2007，316，5827：	1
9	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	ENGELMAN J A ZEJNULLAHU K MITSUDOMI T	2007	Science2007，316，5827：	1
10	Targeting PI3K signalling in cancer:opportunities,challenges and limitations显示文摘	ENGELMAN J A	2009	Nat Rev Cancer2009，9，8：	1
11	Ginkgo biloba extract (Egb) improves postischemic function in isolated preconditioned working rat hearts显示文摘	Tosaki A Engelman DT Pali T	1994	Coron Artery Dis1994，5，5：	1
12	The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts显示文摘	Tosaki A Engelman DT Engelman RM	1996	Cardiovasc Res1996，31，：	1
13	Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR - amplified lung cancer 显示文摘	Jeffrey A Engelman Toru Mukohara Kreshnik Zejnullahu	2006	J Clin Invest2006，116，：	1
14	The evolution of diabetic response to ischemia/ reperfusion and preconditioning in isolated working rat heart显示文摘	TOSAKI A ENGELMEN D T ENGELMAN R M	1996	Cardiovasc Res1996，31，：	1
15	Fast-track recovery of the coronary bypass patient 显示文摘	Engelman R M Rousou J A Flack J E 3rd	1994	Ann Thorac Surg1994，58，6：	1
16	Tricuspid annuloplasty,Fiveand one-half years experience with 78 patients显示文摘	Boyd A D Engelman R M Isom O W	1974	Thorac Cardiovasc Surg1974，68，：	1
17	Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis显示文摘	Alice T Shaw Beow Y Yeap Benjamin J Solomon Gregory J Riely Justin Gainor Jeffrey A Engelman Geoffrey I Shapiro Daniel B Costa Sai-Hong I Ou Mohit Butaney Ravi Salgia Robert G Maki Marileila Varella-Garcia Robert C Doebele Yung-Jue Bang Kimary Kulig Pauli	2011	Lancet Oncology2011，，11：	1
18	Activity and safety of crizotinib in patients with ALK -positive non-small-cell lung cancer: updated results from a phase 1 study显示文摘	D Ross Camidge Yung-Jue Bang Eunice L Kwak A John Iafrate Marileila Varella-Garcia Stephen B Fox Gregory J Riely Benjamin Solomon Sai-Hong I Ou Dong-Wan Kim Ravi Salgia Panagiotis Fidias Jeffrey A Engelman Leena Gandhi Pasi A J?nne Daniel B Costa Geoffrey	2012	Lancet Oncology2012，，10：	1
19	PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib 显示文摘	Engelman J A Zejnullahu K Gale C M	2007	Cancer Res2007，67，11：	1
20	The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts显示文摘	Tosaki A Engelman DT Engelman RM	1996	Cardiovasc Res1996，31，4：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示